← Back to Clinical Trials
Recruiting NCT06053619

NCT06053619 Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06053619
Status Recruiting
Phase
Sponsor University Hospital, Limoges
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2023-11-20
Primary Completion 2025-09-11

Trial Parameters

Condition Stroke
Sponsor University Hospital, Limoges
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 35 Years
Max Age 75 Years
Start Date 2023-11-20
Completion 2025-09-11
Interventions
GaitTrainer and Virtual Reality

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The primary objective of this study is to evaluate the tolerance of the use of immersive virtual reality (VR) during robotic walking rehabilitation sessions by Gait Trainer (GT) in post-stroke patients. Secondary objectives aim to evaluate the motivation to participate in VR sessions compared to conventional sessions, the participants' sense of presence within the virtual environment, and the usability of the rehabilitation device created. Finally, we will report the actual walking time and number of steps stroke patients take in VR sessions and conventional sessions.

Eligibility Criteria

Inclusion Criteria: * Hemiparesis following a first ischemic or hemorrhagic stroke; * subacute phase (15 days to 6 months); * Aged 35 to 75 years; * Non-walking subject (unable to walk 3 x 10 meters without human assistance or Functional Ambulation Classification ≤ 2); * Benefiting from robot-assisted walking rehabilitation in the readaptation and physical medecin department of the Limoges University Hospital; * Having the cognitive abilities to understand and follow simple verbal instructions (MMSE \< 24 or BDAE \< 2) * Be able to give informed consent to participate in this study. Exclusion Criteria: * Have neurological and psychiatric conditions, other than stroke; * Conditions contraindicating the use of virtual reality (e.g., epileptic disorders, major cerebellar syndrome). * Inability to evolve in a virtual environment (MSSQ-Short \> 26) * Patient with acute cardiovascular and respiratory disorders; * Patient who is subject to a legal protection measure or who is unable to give c

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology